Search results for: 'deaf texas and benchmarking'
- Did you mean
- deal terms and benchmarking
- Related search terms
- deaf and alliance
- deaf+and+alliance
- deaf+texas+and+benchmarking
- deaf+teva+and+benchmarking
- texas in therapeutic partnering 2017 2004
-
Genitourinary Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Cancer Diagnostic Collaboration and Licensing Deals 2018-2024November 2024$3,995.00Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2024
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Collaboration Deals in Biotechnology 2019-2024September 2024$3,995.00Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Oncology Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Musculoskeletal Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Musculoskeletal Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2024
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Drug Delivery Collaboration and Licensing Deals 2019-2024November 2024$3,995.00Drug Delivery Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Metabolic Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Metabolic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2024
Learn More
